| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |